Chloroquine Delays Healing of Acetic Acid-Induced Mucosal Damage in the Rat Stomach

  • Adeola T Salami
  • Adeola O Odukanmi
  • Babatunde M Duduyemi
  • Kazeem O Ajeigbe


Chloroquine (CQ) is a 4-aminoquinoline derivative, most widely used in treating malaria. Although previous studies have reported the gastric acid enhancing and pro ulcerogenic effect of CQ, its role in resolution of gastric injury is relatively unknown. In this study, the effect of CQ on acetic acid induced gastric ulceration was investigated. Chronic gastric ulcers were induced in male Wistar rats by serosal application of acetic acid for 60 seconds. Subsequently, the animals were given either 0.1ml normal saline (Group B) or 3mg/kg Chloroquine sulphate (Group C) for three days starting 24 hours after ulcer induction. A control (sham-operated) group of animals (Group A) did not have any ulcer induced. The animals were sacrificed by days 7, 14 and 21 post ulceration for gastric ulcer score. Homogenised gastric tissues were also analysed colorimetrically for malodialdehyde (MDA) estimation.  In another study, basal and stimulated gastric acid secretion was measured using the continuous perfusion technique, after which small sections of the gastric tissue were fixed in formalin for histological evaluation. Statistical analysis was by ANOVA and Bonferoni post-hoc test at p-0.05. Acetic acid produced visible and measurable ulcers in all animals in groups B and C while no visible ulcers were seen in the unulcerated control rats. Ulcer diameter and ulcer index were significantly increased in the Chloroquine-treated group on the 7th, 14th and 21st day post-ulcer induction. Reduction in ulcer diameter (noticeable in all the animals by day 21) was significantly reduced in the chloroquine treated rats. These observations were confirmed by results from microscopy. Compared with the control, basal gastric acid secretion was increased by chloroquine but decreased with days after ulcer induction. There was no significant increase in the percentage change of the histamine stimulated gastric acid secretion between the control and chloroquine treated groups (12.5%, and 15.52%) compared with the basal gastric acid secretion (45.34% and 24.55%) on days 14 and 21 respectively. It is concluded that chloroquine prolongs the natural healing of acetic acid induced ulcer in Wistar rat


Adeniyi O.S, Emikpe B.O., Olaleye S.B (2014). Gastric Mucosa Re-epithelisation, Oxidative Stress and Apoptosis During Healing of Acetic Acid -Induced Ulceration in Thyroxine Treatment and Thyroidectomy on Rats. J. Afr. Ass. Physiol. Sci. 2 (1): 57-66
Ajeigbe, K.O., Olaleye, S.B., Nwobodo, E.O. (2008a). Effects of Amodiaquine Hydrochloride and Artemisinin on Indomethacin induced Lipid peroxidation in rats. Pak. J. Biol. Sci., 11 (17): 2154-2158.
Ajeigbe, K.O., Nwobodo, E.O., Oyesola, T.O., Ofusori, D.A., Olaleye, S.B. (2008b). Chloroquine phosphate potentiates indomethacin and HCl/Ethanol-induced gastric mucosa injury in rats. Int. J. Pharmacol., 4 (6): 482-486.
Ajeigbe K.O., Emikpe B.O., Olaleye S.B. (2012). Augmentation of gastric acid secretion by
chloroquine and amodiaquine in the rat stomach. Niger J. Physiol,Sci. (27): 089-094.

Al Mofleh, I.A. (2010). Spices, herbal xenobiotics and the stomach: Friends or foes? World J Gastroenterol. 16 (22): 2710-2719.
Barth H, Lorenz W, Troidl H (1975). Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric secretion..Br J Pharmacol; 55(3): 321–327.
Bertleff M.J., Lange J.F. (2010). Perforated peptic ulcer disease: a review of history and treatment. Dig Surg.;27(3):161-9..
Brunton, L.L., Lazo, J.S., Parker, L.K. (2005). Pharmacotherapy of gastric acidity, peptic ulcers and gastroesophageal reflux. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th Edition McGraw-Hill Companies.
Chen N., Wilson D.W, Pasay C et al. (2005). Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines. Antimicrobial Agents and Chemotherapy 49 , 2102–2105.
Davies, R.E. (1951). The mechanism of Hydrochloric acid production by the stomach. Biol. Rev.26 (1): 87-120.
Dent J (2002). Gut. Management of reflux disease;50(Suppl 4): iv67–iv71.
Douglas W. B., Stephen G. C., Richard H. H (1990). Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology: Vol. 99,No.2 Pages 345–351.
Falade C.O (2014). Fighting a moving target: malaria the pains and the gains: an inaugural lecture delivered at the University of Ibadan on Thursday, 27 November, 2014.University of Ibadan Press. ISBN:9789788456650
Farombi, E.O., Olowu, B.I., Emerole, G.O. (2000). Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology. 126 (3); 217-224.
Farombi, E.O. (2006). Genotoxicity of chloroquine in rat liver cells: Protective role of free radical scavengers. Cell Biology and Toxicology:22, Issue 3, pp 159–167.
Geibel JP (2005). Role of potassium in acid secretion. World J Gastroenterol;11(34):5259-5265
Ghosh, M.N., Schild, H.O. (1958). Continuous recording of acid gastric secretion in the rat. Brit. J. Pharm. 13: 54-61.
Goodman CA, Coleman PG, Mills AJ. (2000). Economic Analysis of Malaria Control in Sub-Saharan Africa . Geneva: Global Forum for Health Research.
Goodman, C.S., Gilman, B.T. (Eds.), Goodman and Gilman’s:The Pharmacological Basis of Therapeutics, 10th ed. McGraw -Hill, New York,2007:.1005 –1019.
Happi CT, Gbotosho GO, Sowunmi A, Falade CO, Akinboye DO, Gerena L, Kyle DE, Milhous W, Wirth DF, Oduola AM (2004). Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Am J Trop Med Hyg 70: 20-26.
Iskander FA., Ahmed YY., Nassar AM., Tantawy SA., Kamel ZM., Farsi JMA., Abdel-Fattah NA (1990). Experimental studies on the effect of Primaquine (antimalarial drug) on the gastric mucosa of albino rat. Sci. Med. J. Cai. Med. Synd. Vol 2.(2).pg 1-19
Landewe R., Miltenburg A., Verdonk M., Verweij C (1995). Chloroquine inhibits T-cell proliferation by interfering with IL-2 production and responsiveness. Clin. Exp. Immunol, 102:144-151
Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV (2006). Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355: 1959-1966
Magwere, T., Yogeshkumar, S.N., Julia, A.H. (1997). Effects of Chloroquine Treatment on Antioxidant Enzymes in Rat Liver and Kidney. Free Rad Bio.Med. 22(1-2): 321-327
Nneli R. O., Nwafia W. C., Oji J. O. (2007). Diets/dietary habits and certain gastrointestinal disorders in the tropics: a review. Nigerian journal of physiological sciences 22 (1-2): 1-13
Obaseiki-Ebor, E.E., Obasi, E.E. (1986). Aspects of Chloroquine mutagenicity. Mutat Res. 175(2):51-9.
Ogungbamigbe T O, Ojurongbe O, Ogunro P S, Okanlawon B M, Kolawole S O (2008).
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment. Mem Inst Oswaldo Cruz , Rio de Janeiro 103 (1):79-84
Ogunkunle O.O., Fehintola F.A., Ogungbamigbe T.O., Falade C.O. (2011). Comparative cardiac effects of chlorproguanil/dapsone and chloroquine during treatment of acute uncomplicated falciparum malaria infection in Nigerian childrenAfrican Journal of Biomedical research.; 14; 161 -167
Olaleye S.B, Ajeigbe K.O., Emikpe B.E (2012). Effect of Sulfadoxine-Pyrimethamine and Artesunate on Gastric Acid Secretion and Parietal Cell Mass in Rats. Afr. J. Biomed. Res.Vol.15; 23 - 28
Perry M.A., Wadhwa S., Parks D.A., Pickard W., Granger, D.N. (1986). Role of oxygen radicals in ischemia-induced lesions in the cat stomach. Gastroenterology 90: 362-367
Picot, SF., Peyron A., Donadille., Vuillez., Barbe G., Ambroise- Thomas (1993). Chloroquine- induced inhibition of the production of TNF but not IL-6, is affected by disruption of iron metabolism. Immunology, 80:127-133.
Schubert ML . (2005). Gastric secretion. Curr Opin Gastroenterol.;21(6):636-43.
Sylvester C.N., Uchenna I.O., Obienu, Neri P., (2012). Time trends of upper gastrointestinal diseases in Nigeria. Annals of Gastroenterology 25, 1-5
Tarnawski A. (2000). Molecular mechanism of ulcer healing. Drug News & Perspective 13:158-168.
Tarnawski, A., Szabo, I.L., Husain, S.S., Soreghan, B., (2001). Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J. Physiol. Paris 95, 337– 344.
Toler SM (2004). Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy. Exp Biol Med (Maywood).;229(7):607-15.
Tulassay Z, Herszényi L. (2010). Gastric mucosal defense and cytoprotection. Best Pract Res Clin Gastroenterol. 24(2):99-108. doi: 10.1016/j.bpg.2010.02.006.
Ursos L.M., Roepe P.D. (2002). Chloroquine resistance in the malarial parasite, Plasmodium falciparum..Med Res Rev.;22(5):465-91.
Wang J.Y, Yamasaki S., Takeuchi K., Okabe S. (1989). Delayed healing of acetic acid induced gastric ulcers in rats by indomethacin. Gastroenterol. 96:393-402.
Wellems, T. E (1992). How Chloroquine works. Nature. 355, 6356: 108-109.
Wellems T.E., Plowe C.V., (2001). Chloroquine-resistant malaria..J Infect Dis.: 15;184(6):770-6.
WMA/APS (2002). Guiding principles for research involving animals and human beings. Am J. Physiol. Regul. Integr. Comp. Physiol., 283: R281-R283.
Yao, X., Forte, J.G. (2003). Cell biology of acid secretion by the parietal cell. Annu Rev Physiol 65:103-131
Pathology and System Biology